Abstract:Presently, the principal tools to combat malaria are restricted to killing the parasite in infected people and killing the mosquito vector to thwart transmission. While successful, these approaches are losing effectiveness in view of parasite resistance to drugs and mosquito resistance to insecticides. Clearly, new approaches to fight this deadly disease need to be developed. Recently, one such approach–engineering mosquito resident bacteria to secrete anti-parasite compounds–has proven in the laboratory to be highly effective. However, implementation of this strategy requires approval from regulators as it involves introduction of recombinant bacteria into the field. A frequent argument by regulators is that if something unexpectedly goes wrong after release, there must be a recall mechanism. This report addresses this concern. Previously we have shown that a Serratia bacterium isolated from a mosquito ovary is able to spread through mosquito populations and is amenable to be engineered to secrete anti-plasmodial compounds. We have introduced a plasmid into this bacterium that carries a fluorescent protein gene and show that when cultured in the laboratory, the plasmid is completely lost in about 130 bacterial generations. Importantly, when these bacteria were introduced into mosquitoes, the bacteria were transmitted from one generation to the next, but the plasmid was lost after three mosquito generations, rendering the bacteria non-recombinant (wild type). Furthermore, no evidence was obtained for horizontal transfer of the plasmid to other bacteria either in culture or in the mosquito. Prior to release, it is imperative to demonstrate that the genes that thwart parasite development in the mosquito are safe to the environment. This report describes a methodology to safely achieve this goal, utilizing transient expression from a plasmid that is gradually lost, returning the bacterium to wild type status.The intolerable burden of malaria demands the development of novel approaches to fight this deadly disease. Previously, the engineered symbiotic bacterium Serratia AS1 was shown in the laboratory to be able to spread through mosquito populations and render mosquitoes resistant to the parasite. However, a major concern of regulators for the release of such engineered bacteria into the field is that there is no option for "recall" in case something goes wrong. Here we show that Serratia AS1 loses plasmids as it replicates in mosquitoes and in culture, reverting to wild type. We also show that horizontal transfer of the plasmid from Serratia AS1 to other bacteria is extremely rare, as this was undetectable in the mosquito and in culture. Our results suggest that initial field trials can make use of this reversible system whereby released recombinant bacteria expressing anti-plasmodial compounds from a plasmid revert to wild type at a predictable rate.

Driving mosquito refractoriness to Plasmodium falciparum with engineered symbiotic bacteria

Changes in the microbiota cause genetically modified Anopheles to spread in a population

Fighting malaria with engineered symbiotic bacteria from vector mosquitoes

A natural symbiotic bacterium drives mosquito refractoriness to Plasmodium infection via secretion of an antimalarial lipase

Gene Drive and Symbiont Technologies for Control of Mosquito-Borne Diseases

Genetic approaches to interfere with malaria transmission by vector mosquitoes

Self-limiting paratransgenesis

PLASMODIUM FALCIPARUM TRANSMISSION‐BLOCKING PROTEINS SECRETED FROM BACTERIA IN THE MOSQUITO MIDGUT

A Gut Symbiotic Bacterium Serratia marcescens Renders Mosquito Resistance to Plasmodium Infection Through Activation of Mosquito Immune Responses

Combining transgenesis with paratransgenesis to fight malaria

Transgenic Anopheles mosquitoes expressing human PAI-1 impair malaria transmission

Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi

Curing mosquitoes with genetic approaches for malaria control

Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes

Intra-specific diversity of Serratia marcescens in Anopheles mosquito midgut defines Plasmodium transmission capacity

Engineering Resilient Gene Drives Towards Sustainable Malaria Control: Predicting, Testing and Overcoming Target Site Resistance

Altered Gut Microbiota and Immunity Defines Plasmodium vivax Survival in Anopheles stephensi

Engineered Gut Symbiotic Bacterium-Mediated RNAi for Effective Control of Anopheles Mosquito Larvae

Genetic engineering and bacterial pathogenesis against the vectorial capacity of mosquitoes

Wolbachia infection-responsive immune genes suppress Plasmodium falciparum infection in Anopheles stephensi

Studies of the Parasite-Midgut Interaction Reveal Plasmodium Proteins Important for Malaria Transmission to Mosquitoes